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The herpes simplex virus type 1 UL12 gene encodes a pH-dependent deoxyribonuclease termed alkaline nuclease. An
N-terminally truncated version of the UL12 gene, called UL12.5, was shown to be translated independently from a subgenic
mRNA which shares its 3 terminus with the full-length UL12 mRNA. We showed previously that the UL12.5 gene product
cannot compensate for the absence of the full-length UL12 gene product (R. Martinez, L. Shao, J. C. Bronstein, P. C. Weber,
and S. K. Weller, 1996, Virology 215, 152–164); however, it was not known whether UL12.5 itself performs an essential function
during lytic viral growth. In this article the initiation codon for the UL12.5 gene product was mapped and altered to create a
gene no longer capable of producing UL12.5. This mutation was introduced into the viral genome to create a virus which was
capable of producing full-length UL12 but not UL12.5. The growth properties of this virus indicate that UL12.5 is not essential
for viral growth in culture. UL12.5 was previously reported to represent a capsid-associated form of alkaline nuclease (J. C.
Bronstein, S. K. Weller, and P. C. Weber, 1997, J. Virol. 71, 3039–3047). Sucrose sedimentation analysis of capsids from cells
infected with wild-type or mutant viruses indicates that both UL12 and UL12.5 are found in fractions from across the sucrose
gradient which do not always correlate with the presence of viral capsids. Furthermore, UL12.5 is found in fractions across
the gradient even in cells infected under conditions in which no capsids are formed. These results indicate that UL12.5 doesINTRODUCTION
Herpes simplex virus type 1 (HSV-1) encodes an exo-
nuclease termed alkaline nuclease, the product of the
UL12 open reading frame. The UL12 gene represents a
626 amino acid open reading frame predicted to encode
a protein with a molecular weight of 67 kDa (McGeoch et
al., 1986b, 1988). The alkaline nuclease has been impli-
cated in the processing of DNA replication intermediates
during infection (Goldstein and Weller, 1998b; Martinez et
al., 1996a). We previously constructed a UL12 null mutant
(AN-1) in which 917 bp of UL12 sequence was replaced
by a lacZ insertion (AN-1). AN-1 is severely compromised
in the production of progeny virus with yields 0.1–1% that
of wild-type virus (Shao et al., 1993). In the absence of
UL12, we have observed that DNA-containing capsids
are formed; however, they are not transported from the
nucleus to the cytoplasm (Shao et al., 1993). Further-
more, increased levels of abortive A capsids accumulate.
We have proposed that in the absence of UL12, aberrant
genomes are produced and packaged, resulting in the
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248formation of DNA-containing capsids which are not com-
petent to leave the nucleus. Furthermore, empty capsids
accumulate presumably due to disgorgement of aberrant
genomes.
The following five 3-coterminal mRNAs have been
mapped in the region of the HSV genome responsible for
encoding UL12: 4.5, 3.9, 2.3, 1.9, and 0.9 kb (Costa et al.,
1983; Draper et al., 1986). The 2.3-kb mRNA encodes
UL12 and is expressed as an early  message (see Fig.
1). The 4.5-, 3.9-, and 0.9-kb messages encode the prod-
ucts of the UL14, UL13, and UL11 genes, respectively.
The 1.9-kb message was predicted to encode an N-
terminally truncated version of the UL12 gene, and in
vitro translation of the 1.9-kb message produces a 54- to
60-kDa protein (Costa et al., 1983). We previously con-
structed a viral mutant, AN-F1, in which the full-length
UL12 open reading frame was interrupted by the inser-
tion of two base pairs 11 bp downstream of the initiation
codon of UL12 (Martinez et al., 1996b) (See Fig. 1). The
resulting virus, AN-F1, was not able to produce full-length
UL12; however, a smaller protein of 55 kDa, which reacts
with UL12-specific antisera, was detected. The truncated
version of UL12 was named UL12.5, and it was ex-
pressed under conditions in which no UL12 was present.
This result was interpreted to indicate that it could benot specifically associate with viral capsids. Taken togethe
role in lytic viral infection. © 2002 Elsevier Science (USA)
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0042-6822/02 $35.00data indicate that UL12.5 is not likely to play an important
produced by an independent mRNA, most likely the
1.9-kb species previously reported by Costa et al. (Costar, these
et al., 1983; Draper et al., 1986). In addition, the pheno-
type of the AN-F1 (UL12UL12.5) viral mutant was iden-
tical to that of AN-1 (UL12UL12.5) mutant, suggesting
that UL12.5 cannot compensate for the loss of UL12
(Martinez et al., 1996b). It is still not known whether
UL12.5 plays an additional function during lytic growth.
Both the UL12.5 protein and its 1.9-kb message are
expressed with early or  kinetics (Bronstein et al., 1997;
Draper et al., 1986). The UL12.5 protein is present in
significantly lower abundance than the UL12 protein dur-
ing infection (Bronstein et al., 1997), which is consistent
with the threefold lower expression of the 1.9-kb tran-
script relative to the full-length 2.3-kb transcript (Draper
et al., 1986). In cells infected with AN-F1, the UL12.5
protein is completely insoluble; however, solubilized ex-
tracts from infected cells demonstrate that UL12.5 retains
enzymatic activity (Bronstein et al., 1997). Consistent with
this result, it has been shown that an expression con-
FIG. 1. The HSV-1 genome showing the positions of the 2.3- and 1.9-kb mRNAs encoding full-length UL12 and the N-terminally truncated UL12.5,
respectively, are shown. The genomic coordinates of the UL12 gene are 25011–26889 (McGeoch et al., 1986a). Below the UL12 and UL12.5 genes,
diagrams of the UL12 expression plasmids used in this study are shown. UL12 was cloned into the amplicon expression plasmid pF1, in which
full-length UL12 expression is driven from the CMV promoter. UL12.5 gene expression would presumably be driven from the endogenous promoter
for the 1.9-kb mRNA. pF1-CMV-AK can express both UL12 and UL12.5. Mutant versions of pF1-CMV-AK are shown below. The 2-bp insertion resulting
in a frameshift mutant introduces a new BamHI site in the ANF1 mutation; the point mutation leading to the substitution of M127 with phenylalanine
introduces a TfiI site and the M185 substitution to leucine introduces a BsaI site. Various combinations of double mutant plasmids were constructed.
The data showing protein expression from these clones is shown in Fig. 2 and is summarized on the right side of this figure. On the bottom line, the
AN-1 deletion–insertion mutation is shown.
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struct of UL12 lacking the N-terminal 127 amino acids
retains nuclease activity (Henderson et al., 1998). Bron-
stein et al. (1997) demonstrated that UL12.5 is associated
with both intranuclear capsids and virions, indicating that
it may play an important role in infection.
In this article, we map the initiation codon for the
UL12.5 gene product and introduce a conservative
change at this codon which eliminates UL12.5 without
altering the expression of full-length UL12. The resulting
mutant, M127F, has allowed us to analyze the role of the
UL12.5 protein during infection. Sucrose sedimentation
analysis of capsids from cells infected with wild-type or
mutant viruses was performed to analyze the association
of UL12.5 with viral capsids. We conclude that UL12.5 is
not essential for lytic growth and that the apparent as-
sociation of UL12.5 with viral capsids may be the result of
protein aggregation rather than specific association.
RESULTS
Mapping the initiation codon for the UL12.5 gene
product
To determine the requirement for UL12.5 expression
during HSV-1 replication, we decided to alter the UL12.5
start codon with a conservative amino acid change. Such
a mutation should have little effect upon UL12 activity,
while eliminating UL12.5 translation. The UL12.5 tran-
script has been mapped (Costa et al., 1983), and we
considered the in-frame methionines at positions 127
and 185 as being potential candidates for the start site of
the UL12.5 gene product based on the size of the pre-
dicted ORF and codon start site preferences. In-frame
methionines are also present at 215, 274, 328, 334, 376,
and 390. We mutated M127 to a phenylalanine, since
sequence alignment data revealed a phenylalanine at
this position in many of the UL12 homologs in other
herpesviruses. M185 was substituted with a leucine.
These substitutions were constructed in the amplicon-
based CMV promoter expression plasmid (F-CMV se-
ries) (Fig. 1) (see Materials and Methods).
Expression by transfection
The ability of clones bearing the M127F and M185L
mutations to express UL12 and UL12.5 was tested in
both infected and transfected cells expressing wild-type
and mutant versions of UL12 and UL12.5 by Western blot
analysis using a polyclonal antibody raised against the
entire UL12 protein expressed in Escherichia coli. Al-
though the UL12 gene is predicted to encode a protein
with a molecular weight of 67 kDa, full-length UL12 pro-
tein migrates at 85 kDa. The difference between the
predicted and apparent molecular weights has been
explained by the presence of a proline-rich N-terminus.
Infected cells are shown on the right-hand portion of Fig.
2 (lanes 7–10). In cells infected with wild-type KOS, a
full-length UL12 protein at 85 kDa is apparent as well as
the UL12.5 protein at 55 kDa (marked with an asterisk)
(Fig. 2, lane 7). As expected, cells infected with AN-1
exhibit neither band (Fig. 2, lane 8). As previously re-
ported, cells infected with AN-F1 exhibit only the 55-kDa
UL12.5 band (Fig. 2, lane 9). Cells infected with a viral
mutant bearing the M127F mutation (described below)
exhibit the full-length UL12 product at 85 kDa; however,
no UL12.5 gene product is present, despite the presence
of bands migrating just above the UL12.5 band (lane 10).
These bands likely represent degradation products of
full-length UL12, since they are only seen in cells which
are capable of producing the full-length protein. The
M127F extract contains at least two degradation prod-
ucts migrating near UL12.5, but does not appear to con-
tain the UL12.5 band. Because the presence of the po-
tential breakdown products complicates the analysis of
whether the M127F virus produces UL12.5, we analyzed
cells transiently transfected with amplicon-expression
plasmids bearing wild-type (pF1-CMV-AK) and mutant
forms of the UL12 gene (Fig. 2, lanes 2–5). As expected,
mock-transfected cells exhibited no staining (Fig. 2, lane
1); however, cells transfected with the wild-type expres-
sion clone contain major species of 85 and 55 kDa. In
these transfected cells, even more putative degradation
products with intermediate mobilities were observed
(Fig. 2, lane 2). Addition of protease inhibitors did not
significantly reduce the amount of degradation product
(data not shown). In contrast, an amplicon plasmid de-
FIG. 2. Western blot of extracts of cells infected mutant viruses or
transiently transfected with various wild-type and mutant expression
plasmids. Vero cells were mock transfected (lane 1) or transfected with
2 g of the following plasmids: pF1-CMV-AK (lane 2); pF1-CMV-ANF1
(lane 3); pF1-CMV-ANF1(M127F) (lane 4); or pF1-CMV-ANF1(M185L)
(lane 5). Vero cells were infected with each of the following viruses at
an m.o.i. of 3 PFU/cell: lane 6, mock; lane 7, KOS; lane 8, AN-1; lane 9,
AN-F1; lane 10, M127F. At 24 h posttransfection or 16 h postinfection
cells were lysed, and extracts subjected to electrophoresis on an 12%
SDS–polyacrylamide gel. Following Western blotting, UL12 gene prod-
ucts were detected with antibody BWp12. The position of the UL12.5
gene product is indicated by an asterisk. Molecular weight markers are
shown on the left.
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signed to express the frameshift mutation AN-F1 exhib-
ited only the 55 kDa and a faster migrating band (Fig. 2,
lane 3), supporting the notion that the intermediate
bands represent degradation products of the full-length
UL12. To determine whether the methionine mutants are
capable of expressing the UL12.5 band, we moved both
the M127F and the M185L mutations into the AN-F1
mutant background which cannot express the full-length
UL12 protein. These constructs would not make full-
length UL12 and would, therefore, not contain degrada-
tion products. In cells transfected with the AN-F1/M127F
double-mutant amplicon, neither the full-length nor the
UL12.5 band is present (Fig. 2, lane 4). In cells trans-
fected with the AN-F1/M185L double-mutant amplicon,
only the 55-kDa UL12.5 band is apparent, as would be
expected if it were still able to synthesize UL12.5 (Fig. 2,
lane 5). Therefore, we conclude that the M127F mutation
abrogates the synthesis of UL12.5. It is formally possible
that proteolytic breakdown products of UL12 may substi-
tute and play a role in the viral life cycle analogous to the
UL12.5 protein. For reasons described below, we favor
the notion that the proteolytic breakdown occurs during
the lysis of cells and that the bands which migrate at
positions near to UL12.5 do not play a role in HSV
replication.
Generation of the M127F mutant virus
The M127F mutation was introduced into the viral
genome by marker transfer, as described under Materi-
als and Methods. The progeny from three independent
transfections were triple-plaque-purified. To confirm the
introduction of the desired mutation, DNA from each of
the viral stocks was digested with TfiI, subjected to gel
electrophoresis, and hybridized to a radiolabeled UL12
probe. The introduction of a novel TfiI site resulted in the
loss of a 2.3-kb UL12-containing fragment, a gain of 1.9
kb, and 0.4-kb fragments in all three mutants (data not
shown). To confirm that the desired mutation was
present, DNA from one of the recombinant viruses
(M127F-1) was amplified by PCR, subcloned, and se-
quenced with the L127 primer (5-TCCGCGGTCCAC-
CATAC-3) using a Sequenase kit (U.S. Biochemicals,
Cleveland, OH). No additional mutations were found, and
M127F-1 was used in subsequent experiments (data not
shown).
Growth properties of the M127F mutant virus
Next we asked whether the inability to express the
UL12.5 gene product resulted in a growth defect. To
measure the efficiency of virus production, Vero cells
were infected with KOS, M127F, AN1, or ANF-1 at an
m.o.i. of 1 PFU/cell and harvested at various times up to
48 h postinfection (Fig. 3). The growth curve shown in
Fig. 3 indicates that the M127F virus grows as well as
wild-type; whereas, as previously reported, AN-1 and
AN-F1 were severely compromised for virus production,
exhibiting a two to three log reduction in yields com-
pared to wild-type KOS and M127F. Therefore, the inabil-
ity to express UL12.5 did not impair viral growth. To
confirm this result, transient complementation experi-
ments were performed in which Vero cells were trans-
fected with amplicon-based expression plasmids and
superinfected with AN-1. The viral progeny were titered
on complementing 6-5 cells. In this type of transient
complementation test, plasmids bearing the wild-type
version of UL12, M127F, and M185L were able to com-
plement the null mutant, whereas plasmids bearing the
AN-F1 mutation were not (data not shown). Thus we can
conclude that UL12.5 is not essential for viral growth.
UL12.5 in capsids
In previous experiments, UL12.5 was found entirely in
the insoluble fraction of KOS-infected cell lysates,
whereas UL12 was almost entirely soluble (Bronstein et
al., 1997). Sucrose gradient analysis of capsids isolated
from infected cells indicated UL12.5 was found associ-
ated with virions and capsid fractions. This result was
interpreted to indicate that the product of the UL12.5
gene is a capsid-associated nuclease which may play a
role in processing of genomic DNA during encapsida-
tion. In this article, capsids were isolated from KOS- and
various mutant-infected cells and subjected to sucrose
gradient centrifugation and fractions examined for the
presence of UL12 and UL12.5 by Western blot analysis.
The presence of the major capsid protein, VP5, was used
to indicate which fractions contained A, B, and C capsids
(Fig. 4A). In cells infected with KOS, both UL12 and
UL12.5 were detected throughout the gradient, whereas
FIG. 3. Growth curve of KOS and alkaline nuclease mutants. Sepa-
rate plates of Vero cells were infected with either KOS (– – E – –), AN-1
(——), AN-F1 (—E—), or M127F (—F—) at an m.o.i. of 1
PFU/cell. Time points were harvested at 12, 24, and 48 hpi. Total viral
yield was determined by titration on permissive 6-5 cells.
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VP5 is seen predominantly in fractions known to contain
A, B, and C capsids (Fig. 4A). In cells infected with the
M127 virus, the UL12 protein is seen across the gradient,
but no bands in the vicinity of UL12.5 are seen (Fig. 4B).
In cells infected with AN-F1 (UL12, UL12.5) no UL12
is seen, and UL12.5 is seen in several fractions across
the gradient (Fig. 4C). In these experiments, it was diffi-
cult to determine whether the UL12.5 was specifically
associated with capsid fractions or was present across
the gradient as a result of nonspecific aggregation. To
definitively answer this question, we analyzed capsids
from cells infected with a ts mutant (tsG8) in the major
capsid protein, shown to be incapable of forming A, B, or
C capsids (Schaffer et al., 1973; Weller et al., 1987).
Figure 5 shows that in cells infected with KOS or tsG8
(1178) at 34°C, capsid forms are seen in the expected
fractions, while UL12.5 is present across the gradient.
Similar results were obtained in cells infected with KOS
at 39.5°C (Fig. 6A) except that UL12.5 is not distributed
as broadly across the gradient. On the other hand, in
cells infected with tsG8 at 39.5°C (Fig. 6B), no capsids
were observed; furthermore, no VP5 was associated with
FIG. 4. Sucrose gradient analysis of capsids from KOS- or alkaline nuclease mutant-infected cells. Infected cell lysates were fractionated by
ultracentrifugation on a 15–50% (w/v) sucrose gradient as described under Materials and Methods. Thirteen fractions were collected and examined
by ECL immunoblotting (for VP5 protein) or by alkaline phosphatase immunoblotting (for UL12 and UL12.5 proteins). The positions of A, B, and C
capsids as determined by VP5 position are marked. (A) KOS-infected cells; (B) M127F-infected cells; (C) AN-F1-infected cells.
FIG. 5. Sucrose gradient analysis of lysates from KOS- or tsG8-
infected cells at 34°. Capsids were isolated and fractions collected as
described under Materials and Methods and examined by ECL immu-
noblotting for both VP5 and UL12 and UL12.5 proteins. In B, the UL12
and UL12.5 bands migrated in a broader band than normally seen.
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any gradient fraction expected to contain capsids. UL12
and UL12.5 were still seen in fractions throughout the
gradient. Thus although the position of UL12.5 in some
gradients appears to migrate with capsid-containing
fractions (Figs. 4C and 6A), in other gradients UL12 and
UL12.5 are distributed more widely across the gradient
with no apparent correlation to position of capsids (Figs.
4A and 5B). The most convincing evidence, however, that
UL12 and UL12.5 are not specifically associated with
capsids comes from the distribution of UL12 and UL12.5
in gradients which do not contain capsids at all (Fig. 6B).
DISCUSSION
Alkaline nuclease is well conserved throughout the
herpesvirus family, suggesting that it plays an important
role in the life cycle of herpesviruses. The growth prop-
erties of the null and other mutants of alkaline nuclease
confirm that it is essential for efficient production of
progeny virus (deWind et al., 1994; Gao et al., 1998;
Martinez et al., 1996a; Patel et al., 1996; Weller et al.,
1990). The major defect in UL12 null mutant infections is
manifested at the point of capsid egress from the nu-
cleus; in the absence of UL12, few if any DNA-containing
capsids appear in the cytoplasm (Shao et al., 1993). We
have previously proposed that the defect in egress is due
to the presence of abnormalities in the viral DNA ge-
nome which in turn affects the stability of DNA-contain-
ing capsids. We and others have reported that HSV-1
DNA replication intermediates have a complex branched
structure (Martinez et al., 1996a; Severini et al., 1994,
1996); furthermore, the DNA which accumulates in cells
infected with UL12 null mutants exhibits an altered struc-
ture compared to DNA in cells infected with wild-type
viruses (Martinez et al., 1996a). We have recently re-
ported that UL12 in conjunction with the major single-
strand binding protein, ICP8, can carry out a strand
exchange reaction in vitro (Reuven et al., 2002). This
result is consistent with our previous proposal that UL12
plays a role in DNA recombination and/or genome mat-
uration (Goldstein and Weller, 1998b).
In any model of UL12 function, it is important to deter-
mine which viral gene products are responsible for var-
ious activities and even more importantly are required for
lytic viral growth. The UL12 gene has an unusual struc-
ture, in that a subgenic mRNA is expressed which en-
codes an N-terminally truncated viral gene product des-
ignated UL12.5. Alkaline nuclease is well conserved
among all members of the herpesvirus family for which
sequence information is available: UL12 homologues all
contain seven conserved motifs (Goldstein and Weller,
1998a; Martinez et al., 1996b). Interestingly, HSV-1 and
HSV-2 contain approximately 120 amino acids at their
N-terminus, which are not shared with homologues from
the other herpesviruses (Martinez et al., 1996b). In fact,
for the HSV-1 gene the first conserved region, motif I, is
located at residue 217, leading to the suggestion that
UL12.5 may encode an enzymatically active form of the
enzyme. This suggestion was confirmed by Bronstein et
al., who showed that UL12.5 isolated from cells infected
with ANF1 which only express UL12.5 retains endo- and
exonuclease activities (Bronstein et al., 1997). Additional
biochemical characterization revealed that UL12.5 pro-
tein was similar to full-length UL12 with respect to pH
optimum, ionic strength, and divalent cation require-
ments. Bronstein et al. demonstrated that UL12.5 ap-
peared to be specially associated with both intranuclear
capsids and virions (Bronstein et al., 1997). The finding
that the UL12.5 protein represents a capsid-associated
form of AN which exhibits nucleolytic activity suggests
that it may play some role in the processing of genomic
DNA during encapsidation. We previously showed that
expression of UL12.5 could not relieve the growth de-
fects of a UL12 null mutant virus (Martinez et al., 1996b),
but the question of whether UL12.5 by itself is essential
for lytic viral growth was not addressed in previous
studies on UL12.5. Furthermore, the start codon of
UL12.5 had not been mapped.
In the present study, the start site of the UL12.5 was
mapped to Methionine 127 and a mutation in which this
methionine was changed to phenylalanine was con-
structed and introduced into the viral genome. The mu-
tant M127F exhibits wild-type growth properties in Vero
cells, suggesting that UL12.5 is not essential for lytic viral
FIG. 6. Sucrose gradient analysis of lysates from KOS- or tsG8-
infected cells at 39° (nonpermissive temperature). Capsids were iso-
lated and fractions collected as described under Materials and Meth-
ods and examined by ECL immunoblotting for both VP5 and UL12 and
UL12.5 proteins. Exposures were approximately 3 min, except for VP5
panel of (B), which was exposed for 30 min to emphasize that no VP5
was present in the gradient fractions.
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growth. A formal possibility exists, however, that UL12.5
or a protein of a similar size as UL12.5 is essential and
that in our experiments, proteolytic fragments derived
from full-length UL12 may substitute for the loss of
UL12.5 in the M127F mutant. While we cannot rule out
this possibility, we have shown that the sucrose gradient
fractions from cells infected with M127F do not contain
detectable UL12.5-related fragments. Thus, we can con-
clude that such proteolytic fragments do not appear to
associate with capsids or even throughout the gradient
as bone fide UL12.5 does when it is expressed. It is more
likely that the fragments seen in extracts are a result of
proteolysis which occurs during or after cell lysis and
that they are not actually present in vivo in infected cells.
In summary we conclude that UL12.5 is not essential for
viral lytic growth.
Several examples of similar in-frame truncation prod-
ucts encoded independently of their full-length primary
products have been detected in the HSV-1 genome. The
US1.5 gene is an independently transcribed and trans-
lated truncated version of the US1 (ICP22) gene (Carter
and Roizman, 1996a,b); the UL8.5 gene appears to en-
code an N-terminally truncated version of UL9 (Barada-
ran et al., 1994, 1996). The UL15.5 gene is independently
expressed from the UL15 gene (Baines et al., 1997; Yu et
al., 1997; Yu and Weller, 1998a,b); and the UL26.5 gene is
expressed from an independent mRNA within the UL26
gene (Liu and Roizman, 1991; Matusick-Kumar et al.,
1994). For UL1.5 and UL8.5 it is not known whether the
truncated versions of the genes play a role in viral infec-
tion distinct from the full-length products. The UL15.5
gene product has been shown to be dispensable for viral
growth (Yu and Weller, 1998a), while the UL26.5 protein is
known to play a very important role as the scaffold
protein during viral assembly. Mutational analysis has
indicated that both UL26 and UL26.5 are required for
optimal viral growth (Matusick-Kumar et al., 1994). It is
not clear why HSV-1 expresses a nonessential protein
such as UL12.5. It is possible that UL12.5 plays a role in
viral replication in animals but not in cell culture. Alter-
natively, UL12.5 may be involved in establishing or main-
taining latent infection. It is also possible that UL12.5 is
a pseudogene, perhaps a remnant of the process lead-
ing to the evolution of the full-length UL12 gene and is
therefore no longer necessary. As mentioned above, the
gene structure of UL12 is unusual in that the N-terminus
of both HSV-1 and HSV-2 UL12 is approximately 120
amino acids longer than that of all other UL12 homo-
logues. Thus it is possible that at some point during
evolution, an additional function was added to the UL12
protein, creating the full-length version of UL12. Thus, the
continued expression of UL12.5 may be superfluous.
Previous work with UL12.5 indicates that it is com-
pletely insoluble in infected cells and may be associated
with both intranuclear capsids and virions (Bronstein et
al., 1997). Furthermore, virions treated with guanidine
hydrochloride (so-called G capsids) also retained some
UL12.5, indicating a close association. In this study, su-
crose sedimentation analysis of capsids from cells in-
fected with wild-type or mutant viruses indicates that
both UL12 and UL12.5 are found in fractions from across
the sucrose gradient, which do not always correlate with
the presence of viral capsids. Furthermore, UL12.5 is
found in fractions across the gradient even in cells in-
fected under conditions in which no capsids are formed.
These results indicate that UL12.5 does not specifically
associate with viral capsids. The most likely explanation
for the appearance of UL12.5 across the gradient may be
aggregation, as UL12.5 is known to be insoluble in in-
fected cell lysates. The previous observation that UL12.5
is seen in G capsids may reflect a nonspecific associa-
tion with capsids which are present in some of the same
gradient fractions. We cannot rule out however the pos-
sibility that some UL12.5 is incorporated into capsids;
however, it seems unlikely that it plays an important role
in lytic viral infection.
MATERIALS AND METHODS
Cells and viruses
African green monkey kidney cells (Vero; American
Type Culture Collection, Rockville, MD) were propagated
as described previously (Weller et al., 1983). The S22 and
6-5 cell lines, which are permissive for UL12 mutants,
were previously described (Carmichael et al., 1988; Shao
et al., 1993). The KOS strain of HSV-1 was used as the
wild-type virus. The UL12 null mutant virus AN-1
(UL12UL12.5) and the frameshift mutant virus AN-F1
(UL12UL12.5) were previously described (Martinez et
al., 1996b; Weller et al., 1990) (see Fig. 1). TsG8 (ts1178),
a temperature-sensitive mutation in the UL19 (VP5 gene),
was previously described (Schaffer et al., 1973; Weller et
al., 1987).
Plasmids
The plasmid pAK, containing the UL12 gene and its
promoter, was described in Martinez et al., 1996b. The
amplicon plasmid pF1-CMV containing the HSV-1 oriS
sequence and the “a” sequence was generously pro-
vided by Ann D. Kwong (Hong et al., 1996). The plasmid
pF1-CMV-AK in which the UL12 gene is expressed from
the CMV promoter was described in (Goldstein and
Weller, 1998a). To generate pUC119-BD22, the UL12-
containing EcoRI–HindIII fragment from M13-BD22 (de-
scribed in Martinez et al., 1996b) was cloned into the
EcoRI and HindIII sites of pUC119. To generate pANF1,
the UL12-containing region of M13-BD22 was PCR am-
plified using primers U127 (5-AGGCGATACTGTCGTCG-
GTGGC-3) and L127 (5-TCCGCGGTCCACCATAC-3).
The product was digested with AflII and XhoI and sub-
cloned into pAK, replacing the corresponding fragment,
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to produce pANF1. The plasmid pANF1 was sequenced
to ensure that no secondary mutations were introduced
by the PCR process. To generate plasmid pF1-CMV-
ANF1, a series of subcloning steps were required, as the
ANF1 frameshift mutation is located in close proximity to
the UL12 start site (which, in plasmid pF1-CMV-AK,
contains an artificially introduced BamHI site). First, the
ends of a 0.7-kb XhoI fragment from pF1-CMV-AK were
filled in with Klenow enzyme, and this fragment was
ligated into the SmaI site of pUC119 to generate pUC-
AK/Xho. To generate pANF1/Xho, a 0.5-kb DsaI fragment
from M13-BD22 was used to replace the 0.5-kb DsaI
fragment in pUC-AK/Xho. Finally, to generate pF1-CMV-
ANF1, a 0.7-kb XhoI fragment of pANF1/Xho was ligated
into pF1-CMV-AK, replacing the corresponding XhoI
fragment. See Fig. 1 for a diagram of single and double
mutations in the pF1-CMV-AK background.
Construction of point mutations
Mutations were constructed by two-step PCR (Ausubel
et al., 1997). Primers were obtained from National Bio-
sciences, Inc. (Plymouth, MN). The outside primers were
AlaC (described in Goldstein and Weller, 1998a) and a
M13–24mer (5 AACGCCAGGGTT TTCCCAGTCACGAC-
3). The mutagenic primers for making the M127 to F
mutation (ATG to TTC) were as follows, with the mutated
nucleotides bold and underlined: M127F-T (5-coordinate
number 26,520-CTTGATTCTTTCTGGTCGGCGTCGGT-
GATCCC-3), M127F-B (5-coordinate number 26,501-
CCGACCAGAAAGAATCAAGGTCCGGGGAGT-3). M127F
was constructed with the M127F primers, the mutated
PCR product was digested with AflII and XhoI, and the
0.6-kb fragment subcloned into pAK to generate
pAK(M127F). The clone was confirmed by the introduc-
tion of a novel TfiI site and sequenced to ensure that the
PCR process did not generate any secondary mutations.
Then, to generate pF1-CMV-AK(M127F) and pF1-CMV-
ANF1(M127F), a 1-kb Eco 72I/Bsi WI fragment from
pAK(M127F) was ligated into pF1-CMV-AK and pF1-
CMV-ANF1, respectively, replacing the corresponding
fragments.
To generate pF1-CMV-AK(M185L), two-step PCR was
performed as described above. The mutagenic primers
for the M185 to L mutation (ATG to CTC) were M185-
upper (5- coordinate number 26,347 -GGAGGCGGGTCT
CGTGGACCGCGG ACTCGGC-3) and M185-lower (5-
coordinate number - 26,317-CCGAGTCCGCGG TCCAC-
GAGACCC GCCTCCT-3). These substitutions generate
a novel BsaI site. The PCR product was digested with
MscI and BsrGI, and the 0.3-kb fragment was subcloned
into pF1-CMV-AK, replacing the corresponding fragment
in pF1-CMV-AK. Introduction of the desired mutation
was confirmed by the presence of the novel BsaI site.
Thus both the M127F and the M185L mutations were
cloned into the amplicon vector, pF1-CMV, such that the
expression of the full-length UL12 will be driven by the
CMV promoter. It is likely that UL12.5 expression will be
under control of its endogenous promoter in these con-
structs.
Marker transfer
To generate a recombinant virus containing the M127F
mutation, a 3.2-kb SphI fragment from plasmid
pAK(M127F) was cotransfected with infectious AN-1
DNA into 6-5 cells as described (Martinez et al., 1996b).
AN-1 makes blue plaques when plated in the presence
of X-gal due to the presence of the lacZ gene insertion.
White plaques were selected, and three plaques from
independent transfections were triple-plaque-purified.
Introduction of the mutation, with its novel TfiI site, was
confirmed by Southern blotting (data not shown).
Western blotting
UL12 gene products were detected from lysates of
both transfected cells and infected cells as follows. Vero
cells (1 106) were plated onto 60-mm dishes and either
transfected with 2 g of the various plasmid clones
using Lipofectamine (Life Technologies, Grand Island,
NY) or infected at an m.o.i. of 3 with various viral mutants.
Twenty-four hours posttransfection or 16 h postinfection,
the cells were scraped from the plates and pelleted in a
Beckman TJ-6 centrifuge at 2000 rpm for 10 min. Cell
pellets were rinsed in PBS and resuspended in 350 l
1 SDS–PAGE loading buffer (50 mM Tris–HCl, pH 6.8,
2% SDS, 5% -ME, 10% glycerol, and 0.1% bromphenol
blue). Lysates in loading buffer were boiled for 5 min and
50-l aliquots were subjected to electrophoresis on 12%
SDS–polyacrylamide gels. Protein was blotted onto Im-
mobilon P membranes (Millipore, Bedford, MA) and vi-
sualized by alkaline phosphatase reaction (Promega,
Madison, WI). Polyclonal antibody Bwp12, prepared
against the entire UL12 protein expressed in E. coli, was
kindly provided by Peter Weber (Parke-Davis, Ann Arbor,
MI) (Bronstein and Weber, 1996). Bwp12 was used as the
primary antibody at a dilution of 1:10,000 at room tem-
perature for 1 h.
Capsid isolation by sucrose gradient centrifugation
Five 162-cm2 flasks of cells were infected at an m.o.i.
of 5 for 18 h, removed by scraping, and pelleted in a
Beckman TJ-6 centrifuge at 2000 rpm for 15 min. The
pellets were rinsed in PBS and lysed by resuspension in
2 ml PBS to which was added 2 ml of 2 lysis buffer
containing 2% Triton X-100, 1 M NaCl, 2 mM EDTA, 40
mM Tris pH 7.6, and protease inhibitors [one complete
tablet of protease inhibitor cocktail (Roche, Indianapolis,
IN) per 10 mL, 10 g pepstatin (Sigma, St. Louis, MO) per
mL, and 300 l liquid protease inhibitor cocktail for
mammalian cell extracts (Sigma) per 10 mL]. Cells were
freeze/thawed three times and disrupted by sonication
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using a Misonix XL (Farmingdale, NY) fitted with a bath
attachment. The lysate was precleared by centrifugation
at 8000 rpm at 4°C for 30 min in an SW41 rotor. Capsids
were partially purified by pelleting through a cushion of
35% (w/v) sucrose in TNE (500 mM NaCl, 20 mM Tris pH
7.6, 1 mM EDTA) by centrifugation at 24,500 rpm at 4°C
for 60 min in an SW41 rotor. Capsid pellets were sus-
pended in TNE and the capsids purified on 20–50%
(wt/vol) sucrose gradients produced on a BioComp Gra-
dient Master (Fredericton, N.B., Canada), by centrifuga-
tion at 24,500 rpm at 4°C for 60 min in an SW41 rotor.
Capsid bands were visualized by light scattering, and
fractions of the gradients were collected with a BioComp
Piston Gradient Fractionator, Model 151. Proteins in the
fractions were precipitated with TCA on ice for 10 min,
pelleted, resuspended in 1 SDS–PAGE loading buffer
as described above, and boiled for 5 min. Aliquots of
approximately one-third of the total yield from each frac-
tion were loaded onto duplicate SDS–12% polyacryl-
amide gels. Proteins were blotted onto Immobilon P
membranes as described above. The UL12 gene product
was visualized using the Bwp12 antibody with the Im-
mun-star detection system according to manufacturer’s
instructions (Bio-Rad, Hercules, CA), while the duplicate
gel was probed with a monoclonal antibody against the
major capsid protein VP5 (ABI, Columbia, MD). VP5 was
visualized using ECL (enhanced chemiluminescence)
according to the manufacturer’s instructions (Amersham,
Piscataway, NJ).
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